newsfilter
← Latest News
GlobeNewswire·

Praxis Precision Medicines Announces Third Quarter 2026 Financial Results Date, Investor Day and November Conference Participation

  • Praxis Precision Medicines will report Q3 2026 financial results before markets open on Monday, November 9, 2026.
  • The company will host an Investor Day in New York on Thursday, November 12, 2026, at 8:00 a.m. ET, featuring presentations on ulixacaltamide for Essential Tremor relutrigine for SCN2A/SCN8A epileptic encephalopathies.
  • Senior management will discuss commercial strategy, launch readiness, current treatment landscapes during the Investor Day.
  • A fireside chat at the Guggenheim Securities Inaugural Healthcare Innovation Conference is scheduled for Monday, November 9, 2026, at 9:30 a.m. ET in Boston.
  • A fireside chat at the UBS Global Biopharma Conference will occur on Monday, November 16, 2026, at 10:40 a.m. GMT in London.
  • Senior management will participate in one-on-one investor meetings at the Jefferies Global Healthcare Conference on November 17 18, 2026, in London.
  • Event replays will be available on the company website for approximately 90 days following each event.